Literature DB >> 21796479

Coexistence of non-alcoholic fatty liver disease with elevated alanine aminotransferase is associated with insulin resistance in young Han males.

Rui Wang1, Qiang Lu, Ji Feng, Fuzai Yin, Chunmei Qin, Bo Liu, Yali Liu, Xiaoli Liu.   

Abstract

Elevated alanine aminotransferase (ALT) and non-alcoholic fatty liver disease (NAFLD) have been associated with insulin resistance (IR). The objective of this study was to determine whether elevated ALT and NAFLD were useful for early and definitive determination of IR and to compare their coexistence with conventional risk factors in young Han males. Anthropometric and metabolic measurements were assessed in 216 young Han males (19.3 ± 0.8 years). NAFLD was diagnosed using ultrasonography, and the homeostasis model assessment of insulin resistance (HOMA-IR) served as an index of IR. Subjects in the fourth HOMA-IR quartile had a significantly higher frequency of abdominal obesity, elevated blood pressure and ALT, and NAFLD compared to subjects in quartiles 1-3 (P < 0.05). Using multivariate logistic regression analysis, risk of IR increased by 2.33-fold (95% CI: 1.00-5.42, P = 0.050) in participants with NAFLD. In addition, the coexistence of NAFLD and elevated ALT were significantly associated with HOMA-IR and participants with both elevated ALT and NAFLD had a 4.65-fold (95% CI: 1.55-13.97, P = 0.006) increased risk of IR. Coexistence of NAFLD and elevated ALT are associated with IR in young Han males and might be useful for early detection of IR as compared to conventional risk factors.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21796479     DOI: 10.1007/s12020-011-9511-0

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  29 in total

Review 1.  Nonalcoholic fatty liver disease.

Authors:  Paul Angulo
Journal:  N Engl J Med       Date:  2002-04-18       Impact factor: 91.245

2.  Visceral fat accumulation and insulin resistance are important factors in nonalcoholic fatty liver disease.

Authors:  Yuichiro Eguchi; Takahisa Eguchi; Toshihiko Mizuta; Yasushi Ide; Tsutomu Yasutake; Ryuichi Iwakiri; Akitaka Hisatomi; Iwata Ozaki; Kyousuke Yamamoto; Yoichiro Kitajima; Yasunori Kawaguchi; Shigetaka Kuroki; Naofumi Ono
Journal:  J Gastroenterol       Date:  2006-05       Impact factor: 7.527

3.  Should nonalcoholic fatty liver disease be included in the definition of metabolic syndrome? A cross-sectional comparison with Adult Treatment Panel III criteria in nonobese nondiabetic subjects.

Authors:  Giovanni Musso; Roberto Gambino; Simona Bo; Barbara Uberti; Giampaolo Biroli; Gianfranco Pagano; Maurizio Cassader
Journal:  Diabetes Care       Date:  2007-12-04       Impact factor: 19.112

4.  The association between increased alanine aminotransferase activity and metabolic factors in nonalcoholic fatty liver disease.

Authors:  Se-Yong Oh; Yong-Kyun Cho; Mun-Su Kang; Tae-Woo Yoo; Jung-Ho Park; Hong-Joo Kim; Dong-Il Park; Chong-Il Sohn; Woo-Kyu Jeon; Byung-Ik Kim; Byung-Ho Son; Jun-Ho Shin
Journal:  Metabolism       Date:  2006-12       Impact factor: 8.694

5.  [The optimal waist circumference cut-off point for identifying cardiovascular risk factors clustering among Chinese adults].

Authors:  Zhao-jun Yang; Wen-ying Yang; Xiao-ping Chen; Guang-wei Li
Journal:  Zhonghua Nei Ke Za Zhi       Date:  2006-05

6.  Limited value of the homeostasis model assessment to predict insulin resistance in older men with impaired glucose tolerance.

Authors:  C M Ferrara; A P Goldberg
Journal:  Diabetes Care       Date:  2001-02       Impact factor: 19.112

Review 7.  Managing nonalcoholic fatty liver disease: recommendations for family physicians.

Authors:  Ignazio Grattagliano; Piero Portincasa; Vincenzo O Palmieri; Giuseppe Palasciano
Journal:  Can Fam Physician       Date:  2007-05       Impact factor: 3.275

8.  Relationship between insulin resistance and serum alanine aminotransferase as a surrogate of NAFLD (nonalcoholic fatty liver disease) in obese Korean children.

Authors:  JangSuk Yoo; SeonYeong Lee; KyuNam Kim; SunMi Yoo; EunJu Sung; JungEun Yim
Journal:  Diabetes Res Clin Pract       Date:  2008-06-20       Impact factor: 5.602

9.  Nonalcoholic fatty liver disease is associated with hepatic and skeletal muscle insulin resistance in overweight adolescents.

Authors:  Sheela Deivanayagam; B Selma Mohammed; Bernadette E Vitola; Gihan H Naguib; Tamir H Keshen; Erik P Kirk; Samuel Klein
Journal:  Am J Clin Nutr       Date:  2008-08       Impact factor: 7.045

Review 10.  Epidemiology of non-alcoholic fatty liver disease in China.

Authors:  Jian-Gao Fan; Geoffrey C Farrell
Journal:  J Hepatol       Date:  2008-11-06       Impact factor: 25.083

View more
  12 in total

1.  Assessment of endothelial function in patients with nonalcoholic fatty liver disease.

Authors:  Yasar Colak; Ebubekir Senates; Atakan Yesil; Yusuf Yilmaz; Oguzhan Ozturk; Levent Doganay; Ender Coskunpinar; Ozlem Timirci Kahraman; Banu Mesci; Celal Ulasoglu; Ilyas Tuncer
Journal:  Endocrine       Date:  2012-06-03       Impact factor: 3.633

2.  Anti-oxidant therapy in non-alcoholic fatty liver disease: the role of silymarin.

Authors:  Ludovico Abenavoli; Natasa Milic; Francesco Capasso
Journal:  Endocrine       Date:  2012-12       Impact factor: 3.633

3.  The role of pro/anti-inflammatory adipokines on bone metabolism in NAFLD obese adolescents: effects of long-term interdisciplinary therapy.

Authors:  Raquel M S Campos; Aline de Piano; Patrícia L da Silva; June Carnier; Priscila L Sanches; Flávia C Corgosinho; Deborah C L Masquio; Marise Lazaretti-Castro; Lila M Oyama; Cláudia M O Nascimento; Lian Tock; Marco Túlio de Mello; Sergio Tufik; Ana R Dâmaso
Journal:  Endocrine       Date:  2012-08       Impact factor: 3.633

Review 4.  Exposure to ambient air particulate matter and non-alcoholic fatty liver disease.

Authors:  Giovanni Tarantino; Domenico Capone; Carmine Finelli
Journal:  World J Gastroenterol       Date:  2013-07-07       Impact factor: 5.742

5.  Serum aminotransferase levels and angiographic coronary artery disease in octogenarians.

Authors:  Shivank A Madan; Dinesh Singal; Snehal R Patel; C S Pitchumoni
Journal:  Endocrine       Date:  2015-04-12       Impact factor: 3.633

6.  New evidence for an association between liver enzymes and pancreatic islet β-cell dysfunction in young obese patients.

Authors:  Li Wang; Juanjuan Zhang; Bokai Wang; Yuwen Zhang; Jie Hong; Yifei Zhang; Weiqing Wang; Weiqiong Gu
Journal:  Endocrine       Date:  2013-04-03       Impact factor: 3.633

7.  Prevalence of insulin resistance and impaired glucose tolerance in a sample of obese Spanish children and adolescents.

Authors:  M P Bahíllo-Curieses; F Hermoso-López; M J Martínez-Sopena; P Cobreros-García; P García-Saseta; M Tríguez-García; J M Marugán-Miguelsanz
Journal:  Endocrine       Date:  2011-10-01       Impact factor: 3.633

Review 8.  Nonalcoholic fatty liver disease: updates in noninvasive diagnosis and correlation with cardiovascular disease.

Authors:  Kuang-Chun Hu; Horng-Yuan Wang; Sung-Chen Liu; Chuan-Chuan Liu; Chung-Lieh Hung; Ming-Jong Bair; Chun-Jen Liu; Ming-Shiang Wu; Shou-Chuan Shih
Journal:  World J Gastroenterol       Date:  2014-06-28       Impact factor: 5.742

Review 9.  Non-Alcoholic Fatty Liver Disease: Metabolic, Genetic, Epigenetic and Environmental Risk Factors.

Authors:  Oriol Juanola; Sebastián Martínez-López; Rubén Francés; Isabel Gómez-Hurtado
Journal:  Int J Environ Res Public Health       Date:  2021-05-14       Impact factor: 3.390

10.  Application of a Novel Prediction Model for Predicting 2-Year Risk of Non-Alcoholic Fatty Liver Disease in the Non-Obese Population with Normal Blood Lipid Levels: A Large Prospective Cohort Study from China.

Authors:  Liwei Ji; Xintian Cai; Yang Bai; Tao Li
Journal:  Int J Gen Med       Date:  2021-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.